|
Clinical variables
|
MIE group (n= 169)
|
OE group (n=169)
|
P
|
|---|
|
Substitution type
| | |
<0.01
|
|
Entire stomach
|
0
|
169 (100%)
| |
|
Gastric tube
|
169 (100%)
|
0
| |
|
Anastomotic type
| | |
<0.01
|
|
Cervical anastomosis
|
169 (100%)
|
0
| |
|
Intrathoracic anastomosis
|
0
|
169 (100%)
| |
|
Omentoplasty
| | |
<0.01
|
|
Yes
|
169 (100%)
|
0
| |
|
No
|
0
|
169 (100%)
| |
|
Histologic type
| | |
0.100
|
|
Squamous cell carcinoma
|
162 (95.9%)
|
148 (87.6%)
| |
|
Adenocarcinoma
|
3 (1.8%)
|
10 (5.9%)
| |
|
Adenosquamous carcinoma
|
3 (1.8%)
|
5 (3.0%)
| |
|
Neuroendocrine carcinoma
|
0 (0.0%)
|
2 (1.2%)
| |
|
Small cell carcinoma
|
1 (0.6%)
|
2 (1.2%)
| |
|
Sarcoma
|
0 (0.0%)
|
2 (1.2%)
| |
|
Tumour size (mean ± SD, cm)
|
4.78 ± 2.17
|
4.80 ± 2.05
|
0.879
|
|
T stage
| | |
0.314
|
|
T1
|
21 (12.4%)
|
20 (11.8%)
| |
|
T2
|
47 (27.8%)
|
49 (29.0%)
| |
|
T3
|
100 (59.2%)
|
82 (48.5%)
| |
|
T4
|
1 (0.6%)
|
18 (10.7%)
| |
|
N stage
| | |
0.974
|
|
N0
|
105 (62.1%)
|
104 (61.5%)
| |
|
N1
|
53 (31.4%)
|
54 (32.0%)
| |
|
N2
|
7 (4.1%)
|
8 (4.7%)
| |
|
N3
|
4 (2.4%)
|
3 (1.8%)
| |
